文献
J-GLOBAL ID:201202266243306911
整理番号:12A0927619
α5β1を標的化する一連の非ペプチドRGDインテグリンアンタゴニストの構造-活性相関:パート1
Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: Part 1
著者 (21件):
DELOUVRIE Benedicte
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
AL-KADHIMI Katherine
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
ARNOULD Jean-claude
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
BARRY Simon T.
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
CROSS Darren A.E.
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
DIDELOT Myriam
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
GAVINE Paul R.
(AstraZeneca R&D, Innovation Center China, Shanghai 201203, CHN)
,
GERMAIN Herve
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
HARRIS Craig S.
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
HUGHES Adina M.
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
JUDE David A.
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
KENDREW Jane
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
LAMBERT-VAN DER BREMPT C
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
LOHMANN Jean-jacques
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
MENARD Morgan
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
MORTLOCK Andrew A.
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
PASS Martin
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
ROONEY Claire
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
VAUTIER Michel
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
,
VINCENT Jennifer L.
(AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, GBR)
,
WARIN Nicolas
(AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, FRA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
22
号:
12
ページ:
4111-4116
発行年:
2012年06月15日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)